martes, 2 de abril de 2019

Bristol-Myers turns to AI startup to accelerate cancer research - STAT

Bristol-Myers turns to AI startup to accelerate cancer research - STAT

Cancer Briefing

STAT Plus: Bristol-Myers Squibb turns to an AI startup to accelerate cancer research

By CASEY ROSS


MEL EVANS/AP
The deal is part of a broader effort to shake up the unwieldy and expensive drug development process by using machine learning to analyze data.

No hay comentarios: